{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:49Z","timestamp":1791920089728,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":416,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009945","name":"FUNAPE\/UFG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009945","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005285","name":"FAPEG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005285","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PROCAD\/CAPES"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.lfs.2012.04.037","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T14:12:54Z","timestamp":1335622374000},"page":"910-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Central pharmacological activity of a new piperazine derivative: 4-(1-Phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester"],"prefix":"10.1016","volume":"90","author":[{"given":"Adriane Ferreira","family":"de Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds Rodrigues","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Oluwagbamigbe","family":"Fajemiroye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablinny Moreira","family":"Galdino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thereza Christina Monteiro","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Menegatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elson Alves","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2012.04.037_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S1516-44462001000400011","article-title":"Tratamento farmacol\u00f3gico do transtorno de ansiedade generalizada: perspectivas futuras","volume":"23","author":"Andreatini","year":"2001","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.lfs.2012.04.037_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0091-3057(97)00457-7","article-title":"Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior","volume":"59","author":"Angrini","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-3472(73)80065-X","article-title":"Tests for emotionality in rats and mice: a review","volume":"21","author":"Archer","year":"1973","journal-title":"Anim Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0020","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0024-3205(02)02414-1","article-title":"Effects of chronic treatment with ipsapirone and buspirone on the C57BL\/6J strain mice under social stress","volume":"72","author":"Avgustinovich","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.04.037_bb0025","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bmc.2005.09.060","article-title":"Structure-intrinsic activity relationship studies in the group of 1-imido\/amido substituted 4-(4-arylpiperazin-1-yl) cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic-like activity","volume":"14","author":"Bojarski","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0028-3908(97)00094-4","article-title":"Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze","volume":"36","author":"Cao","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2012.04.037_bb0035","first-page":"25","article-title":"Screening farmacol\u00f3gico de ansiol\u00edticos: Metodologia laboratorial e compara\u00e7\u00e3o entre diazepam e clorobenzepam","volume":"1","author":"Carlini","year":"1979","journal-title":"Rev Assoc Bras Psiquiatr"},{"key":"10.1016\/j.lfs.2012.04.037_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-8741(86)90072-3","article-title":"Pharmacology of lemon-grass (Cymbopogon citratus Stapf). Effects of teas prepared from leaves on laboratory-animals","volume":"17","author":"Carlini","year":"1986","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.lfs.2012.04.037_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pbb.2006.08.017","article-title":"Anxiolytic-like effect of asiaticoside in mice","volume":"85","author":"Chen","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0149-7634(97)00058-4","article-title":"Biological bases of anxiety","volume":"22","author":"Clement","year":"1998","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.lfs.2012.04.037_bb0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behaviour for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.lfs.2012.04.037_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vascn.2004.11.005","article-title":"Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs","volume":"52","author":"Farkas","year":"2005","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.lfs.2012.04.037_bb0200","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1039\/jr9570003024","article-title":"The preparation of some trinitrophenylpyrazoles","author":"Finar","year":"1957","journal-title":"J Chem Soc"},{"key":"10.1016\/j.lfs.2012.04.037_bb0075","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1016\/j.bmcl.2009.10.014","article-title":"Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists","volume":"19","author":"Gray","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.lfs.2012.04.037_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pbb.2008.11.012","article-title":"Anxiolytic effects of sanjoinine A isolated from Zizyphi spinosi Semen: possible involvement of GABAergic transmission","volume":"92","author":"Han","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hoog","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0090","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1021\/ic0344822","article-title":"Synthesis and photophysics of one mononuclear Mn(III) and one dinuclear Mn(III, III) complex covalently linked to a ruthenium(II) tris(bipyridyl) complex","volume":"42","author":"Johansson","year":"2003","journal-title":"Inorg Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb0205","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0165-0327(11)70004-0","article-title":"Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness","volume":"128S1","author":"Katzman","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.lfs.2012.04.037_bb0100","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.bmc.2009.01.043","article-title":"Synthesis and pharmacological evaluation of new arylpiperazines N-{4-[4-(aryl) piperazine-1-yl]-phenyl}-amine derivatives: putative role of 5-HT1A receptors","volume":"17","author":"Khatri","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb0105","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1021\/ic702015u","article-title":"Double-stranded monohelical complexes from an unsymmetrical chiral Schiff-base ligand","volume":"47","author":"Lalehzari","year":"2008","journal-title":"Inorg Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb0110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1055\/s-1998-2110","article-title":"Mono- and diformylation of 4-substituted phenols: A new application of the duff reaction","volume":"7","author":"Lindoy","year":"1998","journal-title":"Synthesis"},{"key":"10.1016\/j.lfs.2012.04.037_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2012.04.037_bb0120","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.bmcl.2004.10.005","article-title":"Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists","volume":"14","author":"Luo","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.lfs.2012.04.037_bb0125","series-title":"New natural products and plant drugs with pharmacological, biological, or therapeutical activity","first-page":"23","article-title":"Pharmacological approaches to natural product, screening and evaluation","author":"Malone","year":"1977"},{"key":"10.1016\/j.lfs.2012.04.037_bb0130","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/S0968-0896(03)00487-5","article-title":"Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands","volume":"11","author":"Menegatti","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb0135","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.bmc.2010.01.040","article-title":"Searching for multi-target antipsychotics: discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors","volume":"18","author":"Neves","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb9000","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0091-3057(88)90463-7","article-title":"Proconvulsant and anxiogenic effects of n-butyl-\u03b2-carboline-3-carboxilate on endogenous benzodiazepine binding inhibitor from brain","volume":"30","author":"Novas","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0140","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.bmc.2007.07.029","article-title":"The influence of modifications in imide fragment structure on 5-HT1A and 5-HT7 receptor affinity and in vivo pharmacological properties of somo new 1-(m-trifluoromethylphenyl)piperazines","volume":"15","author":"Paluchowska","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.lfs.2012.04.037_bb0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.eurpsy.2007.01.1220","article-title":"A meta-analysis of clinical trials comparing the serotonin (5-HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder","volume":"22","author":"Papakostas","year":"2007","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.lfs.2012.04.037_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.lfs.2012.04.037_bb0155","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.lfs.2004.04.032","article-title":"Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors","volume":"75","author":"Peng","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.04.037_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2012.04.037_bb0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0091-3057(97)00461-9","article-title":"Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs","volume":"59","author":"Rex","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0170","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1016\/j.bmcl.2006.05.030","article-title":"Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease","volume":"16","author":"Sadashiva","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.lfs.2012.04.037_bb0210","unstructured":"Schmitt RLS. Revis\u00e3o sistem\u00e1tica e meta-an\u00e1lise do uso de antidepressivos no transtorno de ansiedade generalizada. Disserta\u00e7\u00e3o (Mestrado em Ci\u00eancias M\u00e9dicas \u2014 Psiquiatria) \u2014 Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, 2003."},{"key":"10.1016\/j.lfs.2012.04.037_bb0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00223980.1946.9917283","article-title":"A simple electronic device for the measurement of gross bodily activity of small animals","volume":"21","author":"Siegel","year":"1946","journal-title":"J Psychol"},{"key":"10.1016\/j.lfs.2012.04.037_bb0215","series-title":"Biometry: the principles and practice of statistics in biological research","author":"Sokal","year":"1981"},{"key":"10.1016\/j.lfs.2012.04.037_bb0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0091-3057(91)90077-F","article-title":"Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light\/dark test","volume":"40","author":"Young","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2012.04.037_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbb.2007.04.013","article-title":"Involvement of 5-HT1A and GABAA receptors in the anxiolytic-like effects of Cinnamomum cassia in mice","volume":"87","author":"Yu","year":"2007","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512002275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512002275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:10:22Z","timestamp":1758399022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320512002275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":40,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0024320512002275"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2012.04.037","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central pharmacological activity of a new piperazine derivative: 4-(1-Phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2012.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}